Home
/
Tango Therapeutics, Inc.
/
Financials
/
Quarterly
Tango Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Tango Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$53.81M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$3.18M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$5.39M
May 12, 2025
Q3
2025
Sep 30, 2024
$11.61M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$19.88M
Aug 5, 2025
Q1
2025
Mar 31, 2024
$6.47M
May 12, 2025
Q3
2024
Sep 30, 2023
$10.73M
Nov 6, 2024
Q2
2024
Jun 30, 2023
$14.60M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$5.77M
May 8, 2024
Q3
2023
Sep 30, 2022
$6.92M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$5.77M
Aug 7, 2023
Q1
2023
Mar 31, 2022
$5.76M
May 9, 2023
Q3
2022
Sep 30, 2021
$6.79M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$18.15M
Aug 10, 2022
Q1
2022
Mar 31, 2021
$6.39M
May 11, 2022
Q3
2021
Sep 30, 2020
($11.26M)
Nov 9, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$15.88M
Nov 4, 2025
Q3
2025
Jun 30, 2025
($38.85M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($38.85M)
Aug 5, 2025
Q3
2025
Mar 31, 2025
($39.88M)
Nov 4, 2025
Q2
2025
Mar 31, 2025
($39.88M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($39.88M)
May 12, 2025
Q3
2025
Sep 30, 2024
($29.17M)
Nov 4, 2025
Q3
2025
Jun 30, 2024
($25.55M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($25.55M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($37.91M)
May 12, 2025
Q2
2025
Mar 31, 2024
($37.91M)
Aug 5, 2025
Q3
2025
Mar 31, 2024
($37.91M)
Nov 4, 2025
Q3
2024
Sep 30, 2023
($22.26M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($20.71M)
Aug 7, 2024
Q3
2024
Jun 30, 2023
($20.71M)
Nov 6, 2024
Q2
2024
Mar 31, 2023
($28.01M)
Aug 7, 2024
Q3
2024
Mar 31, 2023
($28.01M)
Nov 6, 2024
Q1
2024
Mar 31, 2023
($28.01M)
May 8, 2024
Q3
2023
Sep 30, 2022
($29.05M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($24.86M)
Aug 7, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$14.07M
Nov 4, 2025
Q2
2025
Jun 30, 2025
($40.97M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($42.53M)
May 12, 2025
Q3
2025
Sep 30, 2024
($32.88M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($29.55M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($42.26M)
May 12, 2025
Q3
2024
Sep 30, 2023
($25.63M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($23.25M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($30.29M)
May 8, 2024
Q3
2023
Sep 30, 2022
($29.92M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($25.20M)
Aug 7, 2023
Q1
2023
Mar 31, 2022
($25.38M)
May 9, 2023
Q3
2022
Sep 30, 2021
($19.57M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($4.56M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($12.08M)
May 11, 2022
Q3
2021
Sep 30, 2020
($26.76M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($472)
Aug 9, 2021